Valuation Cardinal Health, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 02:00:08 2026-10-01 EDT			5-day change	1st Jan Change
195.60 ^EUR	-0.56%		+0.98%	+11.48%

10-01	Cardinal Health renews contract with CVS Health
10-01	Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	14,240	24,078	23,948	40,098	55,638	53,279	-	-
Change	-	69.09%	-0.54%	67.44%	38.76%	-4.24%	-	-
Enterprise Value (EV) ¹	14,838	24,736	23,907	44,751	59,668	55,644	53,882	50,767
Change	-	66.71%	-3.35%	87.19%	33.33%	-6.74%	-3.17%	-5.78%
P/E	-15.6x	94.6x	28.5x	26x	32.9x	22.5x	19.9x	17.9x
PBR	-20.6x	-8.32x	-7.5x	-14.4x	-19.2x	-45.6x	77.8x	18.1x
PEG	-	-1x	0x	0.3x	2.7x	0.5x	1.5x	1.6x
Capitalization / Revenue	0.08x	0.12x	0.11x	0.18x	0.22x	0.2x	0.19x	0.18x
EV / Revenue	0.08x	0.12x	0.11x	0.2x	0.23x	0.21x	0.19x	0.17x
EV / EBITDA	6.29x	10x	8.42x	14.4x	14.5x	12.5x	11.1x	9.73x
EV / EBIT	7.46x	12x	9.9x	16.1x	16.5x	14.2x	12.5x	10.9x
EV / FCF	5.43x	10.5x	7.35x	24.2x	13.2x	16.3x	13.6x	11.9x
FCF Yield	18.4%	9.53%	13.6%	4.13%	7.58%	6.14%	7.37%	8.42%
Dividend per Share ²	1.96	1.988	2.02	2.02	2.04	2.099	2.141	2.161
Rate of return	3.75%	2.1%	2.05%	1.2%	0.86%	0.91%	0.93%	0.94%
EPS ²	-3.35	1	3.45	6.45	7.23	10.23	11.56	12.84
Distribution rate	-58.5%	199%	58.6%	31.3%	28.2%	20.5%	18.5%	16.8%
Net sales ¹	181,364	205,012	226,827	222,578	254,248	265,859	282,308	298,733
EBITDA ¹	2,358	2,464	2,840	3,112	4,111	4,445	4,842	5,220
EBIT ¹	1,990	2,057	2,414	2,786	3,624	3,911	4,302	4,654
Net income ¹	-933	261	852	1,561	1,714	2,324	2,610	2,954
Net Debt ¹	598	658	-41	4,653	4,030	2,365	602.6	-2,513
Reference price ²	52.27	94.57	98.32	168.00	237.56	230.09	230.09	230.09
Nbr of stocks (in thousands)	272,427	254,600	243,567	238,677	234,206	231,559	-	-
Announcement Date	8/11/22	8/15/23	8/14/24	8/12/25	8/11/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.9x	11.93x	24.23x	0.6%	1,031B
JOHNSON & JOHNSON	29.45x	6.54x	18.31x	2.02%	638B
ABBVIE INC.	33.1x	7.75x	16.02x	2.65%	462B
MERCK & CO., INC.	105.72x	5.91x	25.05x	2.35%	359B
ROCHE HOLDING AG	19x	4.63x	11.48x	2.87%	335B
NOVARTIS AG	20.37x	5.28x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.79x	4.31x	12.28x	2.05%	253B
AMGEN INC.	26.62x	6.92x	12.32x	2.39%	228B
GILEAD SCIENCES, INC.	-45.08x	6.57x	25.65x	2.21%	185B
Average	26.98x	6.65x	17.60x	2.24%	418.21B
Weighted average by Cap.	32.10x	7.72x	18.90x	1.92%